PharmAust Limited (ASX:PAA) is a public company listed on the Australian Securities and Exchange. The principal activities of the company is to develop its own drug discovery intellectual property as well as providing highly specialised medicinal and synthetic chemistry services on a contract basis to clients.
Epichem is an Australian company formed in 2003 to provide services in synthetic and medicinal chemistry to the drug discovery and pharmaceutical industries. With two state-of-the-art laboratories in Perth and Melbourne, Epichem serves an international clientele ranging from small operations to large multinational pharmaceutical companies.
Epichem's ability to excel in a highly competitive global marketplace was recently recognized when in 2010 it won an Australian Export Award. It has achieved this by combining a world class team of highly innovative chemists and a management committed to customer service.
At Epichem, no job is too big or too small and every customer is treated like they are our only customer.
Epichem is a 100% wholly owned subsidiary of PharmAust Limited.